General characteristics and origin
The medications in question belong to the group of endogenous polypeptides. They are sourced from the immune system organs of animals, specifically the thymus gland of cattle. Historically, such medications are considered the first representatives of their class in pharmacology.
This group includes such well-known names as Thymalin and T-activin. Structurally, they are a complex of polypeptide fractions.
Pharmacodynamics and immunological effects
Biologically active substances of the thymus gland exert a complex, multi-level effect on the body's defense mechanisms:
- T-cell link: promote the restoration of the total number and functional activity of T-lymphocytes, and normalize the balance of their subpopulations (regulate the ratio of T-helper to T-suppressor cells).
- B-cell link: lead to a physiological ratio of T- and B-lymphocytes in the body.
- Nonspecific resistance: increase the functional activity of natural killer cells (NK cells) and significantly enhance phagocytosis processes.
- Mediators: stimulate the production of lymphokines.
Clinical application and limitations
In medical practice, these pharmacological agents are traditionally prescribed as part of combination therapy for patients exhibiting a pronounced decrease in cell-mediated immunity.
Nevertheless, modern medical science approaches such prescriptions with caution. A crucial note is that the real efficacy and overall necessity of using such agents in rigorous clinical trials have not been proven.
Adverse effects
Like any complex protein complexes of animal origin, these medications carry certain risks when administered to patients.
The main and most likely adverse effect when using such drugs is various allergic reactions.
Class and exam questions
From which organs are these immunostimulants obtained?
Drugs of this group are isolated from the organs of the immune system, specifically from the thymus gland of cattle.
How do these agents affect cell-mediated immunity?
They restore the number and functions of T-lymphocytes, normalize the ratio of T-helpers and T-suppressors, and stimulate natural killers and phagocytosis.
Has the efficacy of these drugs been proven in clinical trials?
No, within clinical trials, the efficacy and real necessity of using such agents have not been proven.
What adverse effects may occur?
The main possible adverse effect when using such medications is allergic reactions.
What else to study on this topic
- Classification of endogenous polypeptides and other immunostimulants
- Mechanisms of intercellular cooperation of T- and B-lymphocytes
- The role of natural killer cells and phagocytosis in nonspecific resistance
- Principles of conducting clinical trials in pharmacology
- Features of designing combination therapy for immunodeficiency states
Master the entire topic in the «Pharmacology» course
This is a summary. The course covers everything tested in classes and exams.
- Complete study guide on "Thymus preparations" and 5,304 other subject pages
- Assignments and quizzes after every topic — just like in a colloquium
- AI tutor answers questions on the topic anytime
- 116 video lessons on the subject
Other topics in the section "Agents Regulating Immune Processes"
Free video lessons: pharmacologyShort lessons with study notes — no registration required.
Prepared by WhiteCoat Pro faculty in accordance with the medical school curriculum. For educational purposes only.